Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

2000 Vaccine Research Seminars

Future Seminars | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Seminars are held on the NIH campus in Building 40, Conference Rooms 1201 & 1203, on Tuesdays at 4:00 PM (except as noted).





Nov. 1, 2000 Vanessa Hirsch, D.V.M., Sc.D. Laboratory of Molecular Microbiology, NIAID Modified vaccinia virus ankara (MVA) as a potential live vaccine vector for AIDS
July 26, 2000 James Earl King Hildreth, Ph.D., M.D. John Hopkins University School of Medicine Role of ADCC in protection against HIV infection
June 26, 2000 Heinrich G. Göttlinger, M.D. Dana Farber Cancer Institute A general role for ubiquitin ligase in recruitment in retrovirus release
June 19, 2000 Hildegund C.J. Ertl, M.D. The Wistar Institute, Philadelphia, PA Vaccine induced responses to viruses and cancer
June 8, 2000 Richard T. Wyatt, Ph.D. Dana-Farber Cancer Institute HIV-1 gp 120 structural analysis and mechanisms of immune evasion
June 5, 2000 Carol D. Weiss, M.D., Ph.D. Center for Biologics, FDA Lessons from HIV entry
May 25, 2000 Ligia A. Pinto, Ph.D. Experimental Immunology Branch, NIH Novel approaches for immunologic control of HIV infection: Implications for vaccine design
May 10, 2000 Peter D. Kwong, Ph.D. Columbia University The HIV gp120 envelope glycoprotein: structure, function and vaccine design
Apr. 28, 2000 Richard Koup, M.D. The University of Texas Southwestern Medical Center Measuring immune responses and immune reconstitution in HIV infected patients
Apr. 25, 2000 Jeff Frelinger, Ph.D. University of North Carolina An immunologist looks at HIV vaccines
Apr. 13, 2000 Nina Bhardwaj, M.D., Ph.D. Rockefeller University Dendritic cells, apoptosis, and immunity
Mar. 28, 2000 Daniel Douek, Ph.D. University of Texas Southwestern Medical School Immune reconstitution - The thymus and factors that affect its function
Mar. 24, 2000 Ira Berkower, M.D., Ph.D. Center for Biologics, FDA Novel vaccine constructs for enhanced immunogenicity
Mar. 17, 2000 Jonthan Yewdell, M.D., Ph.D. Laboratory of Viral Diseases NIAID Protein folding, unfolding and QC meet the MHC class I antigen processing pathway
Mar. 16, 2000 Jack Bennink, Ph.D. Laboratory of Viral Diseases, NIAID Immunodominance in anti-viral MHC class I restricted T-cell responses
Mar. 13, 2000 George Gao, Ph.D. Harvard University Coordination of alpha/beta T cell receptor and co-receptor CD8 in T cell recognition
Mar. 3, 2000 Guangxia Gao, Ph.D. Columbia University Genetic analysis of viral and cellular functions of retroviral infection
Mar. 2, 2000 Robert Donahue, D.V.M. National Heart, Lung and Blood Institute Non-human primate hematopoietic cell gene therapy
Feb. 28, 2000 Igor Belyakov, M.D., Ph.D. Metabolism Branch, BCI, NIH A rational basis for mucosal vaccination against HIV infection
Feb. 17, 2000 Melisssa Pope, Ph.D. Rockefeller University Presentation of simian immunodeficiency virus by dendritic cells: immune activation versus virus replication
Feb. 11, 2000 Louis Alexander, Ph.D. Harvard Medical School Nef functions that contribute to HIV-1 and SIV pathogenesis
Jan. 21, 2000 Douglas Nixon, M.D., Ph.D. Aaron Diamond AIDS Research Center HIV specific CTL and protection against infection with HIV
Jan. 19, 2000 Robert Seder, M.D. Laboratory of Clinical Investigation, NIAID Vaccine requirements for sustained Th 1 immunity in vivo
Jan. 14, 2000 Dennis Klinman, M.D., Ph.D. Center for Biologics Evaluation and Research, FDA Immunotherapeutic Potential of CpG-containing DNA

View Past Seminars

back to top

Last Updated January 25, 2012